Epidemiology of Diabetes Mellitus in Patients With Psoriatic Arthritis: Current Evidence

IF 8.3 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Jiao Wang, Xuan Zhou, Jiale Chen, Qingyun Wang, Xiaofei Yi, Pengbo Gao, Jingjie He, Shufen Yang, Miao Zhang, Xiaoying Sun, Liu Liu, Xin Li
{"title":"Epidemiology of Diabetes Mellitus in Patients With Psoriatic Arthritis: Current Evidence","authors":"Jiao Wang,&nbsp;Xuan Zhou,&nbsp;Jiale Chen,&nbsp;Qingyun Wang,&nbsp;Xiaofei Yi,&nbsp;Pengbo Gao,&nbsp;Jingjie He,&nbsp;Shufen Yang,&nbsp;Miao Zhang,&nbsp;Xiaoying Sun,&nbsp;Liu Liu,&nbsp;Xin Li","doi":"10.1002/dmrr.70239","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aims</h3>\n \n <p>Diabetes mellitus (DM) is a common comorbidity of psoriatic arthritis (PsA); however, its global prevalence and the impact of treatment exposure remain unclear. This study aimed to assess the global prevalence of DM in patients with PsA using different subgroup analyses.</p>\n </section>\n \n <section>\n \n <h3> Materials and Methods</h3>\n \n <p>A systematic search of PubMed, Embase, the Cochrane Library and the Web of Science was performed from inception until February 2025 for observational studies reporting the prevalence or incidence of DM in PsA patients. Random-effects models were applied to pool estimates, and subgroup, meta-regression, and sensitivity analyses were conducted to explore heterogeneity. Publication bias was evaluated using the Egger's test and the trim-and-fill method.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Sixty-three studies, including 293,582 patients with PsA, were analysed. Patients with PsA included in this study were divided into treatment-disclosed and non-treatment-disclosed groups. DM overall prevalence in patients with PsA was 13.84% in the non-treatment-disclosed population and 13.50% in the treatment-disclosed cohort. Geographically, the comorbidity prevalence rates were higher in South America (37.98%) and Asia (16.76%) than in Europe (12.81%) and North America (12.38%) in the non-treatment-disclosed population. In the treatment-disclosed population, prevalence was also highest in South America (28.13%), followed by Asia (18.30%). Meta-regression analysis identified age, type of DM, region, and study design as contributors to heterogeneity. Evidence of small-study effects was detected in the T2DM subgroup and cohorts receiving systemic therapy plus biologics.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Subgroup analysis shows that the prevalence of DM is associated with the type of study and the region in which the patients were located. These findings support routine metabolic screening for PsA and highlight the need for longitudinal studies to track disease activity, treatment patterns, and metabolic outcomes.</p>\n </section>\n </div>","PeriodicalId":11335,"journal":{"name":"Diabetes/Metabolism Research and Reviews","volume":"42 7","pages":""},"PeriodicalIF":8.3000,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.70239","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes/Metabolism Research and Reviews","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/dmrr.70239","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aims

Diabetes mellitus (DM) is a common comorbidity of psoriatic arthritis (PsA); however, its global prevalence and the impact of treatment exposure remain unclear. This study aimed to assess the global prevalence of DM in patients with PsA using different subgroup analyses.

Materials and Methods

A systematic search of PubMed, Embase, the Cochrane Library and the Web of Science was performed from inception until February 2025 for observational studies reporting the prevalence or incidence of DM in PsA patients. Random-effects models were applied to pool estimates, and subgroup, meta-regression, and sensitivity analyses were conducted to explore heterogeneity. Publication bias was evaluated using the Egger's test and the trim-and-fill method.

Results

Sixty-three studies, including 293,582 patients with PsA, were analysed. Patients with PsA included in this study were divided into treatment-disclosed and non-treatment-disclosed groups. DM overall prevalence in patients with PsA was 13.84% in the non-treatment-disclosed population and 13.50% in the treatment-disclosed cohort. Geographically, the comorbidity prevalence rates were higher in South America (37.98%) and Asia (16.76%) than in Europe (12.81%) and North America (12.38%) in the non-treatment-disclosed population. In the treatment-disclosed population, prevalence was also highest in South America (28.13%), followed by Asia (18.30%). Meta-regression analysis identified age, type of DM, region, and study design as contributors to heterogeneity. Evidence of small-study effects was detected in the T2DM subgroup and cohorts receiving systemic therapy plus biologics.

Conclusions

Subgroup analysis shows that the prevalence of DM is associated with the type of study and the region in which the patients were located. These findings support routine metabolic screening for PsA and highlight the need for longitudinal studies to track disease activity, treatment patterns, and metabolic outcomes.

Abstract Image

银屑病关节炎患者糖尿病的流行病学:最新证据
目的糖尿病(DM)是银屑病关节炎(PsA)的常见合并症;然而,其全球流行情况和治疗暴露的影响仍不清楚。本研究旨在通过不同的亚组分析来评估PsA患者中糖尿病的全球患病率。材料和方法系统检索PubMed、Embase、Cochrane图书馆和Web of Science,从成立到2025年2月,对报告PsA患者中DM患病率或发病率的观察性研究进行了系统检索。随机效应模型应用于池估计,并进行亚组、元回归和敏感性分析以探索异质性。发表偏倚采用Egger’s检验和补齐法进行评价。结果共分析63项研究,包括293,582例PsA患者。本研究纳入的PsA患者分为治疗公开组和非治疗公开组。PsA患者中糖尿病的总体患病率在未公开治疗人群中为13.84%,在公开治疗人群中为13.50%。从地理上看,南美(37.98%)和亚洲(16.76%)的合并症患病率高于欧洲(12.81%)和北美(12.38%)。在接受治疗的人群中,南美洲的患病率也最高(28.13%),其次是亚洲(18.30%)。荟萃回归分析确定年龄、糖尿病类型、地区和研究设计是造成异质性的因素。在接受全身治疗加生物制剂的T2DM亚组和队列中发现了小研究效应的证据。结论亚组分析显示,糖尿病患病率与研究类型和患者所在地区有关。这些发现支持PsA的常规代谢筛查,并强调需要进行纵向研究以跟踪疾病活动、治疗模式和代谢结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes/Metabolism Research and Reviews
Diabetes/Metabolism Research and Reviews 医学-内分泌学与代谢
CiteScore
17.20
自引率
2.50%
发文量
84
审稿时长
4-8 weeks
期刊介绍: Diabetes/Metabolism Research and Reviews is a premier endocrinology and metabolism journal esteemed by clinicians and researchers alike. Encompassing a wide spectrum of topics including diabetes, endocrinology, metabolism, and obesity, the journal eagerly accepts submissions ranging from clinical studies to basic and translational research, as well as reviews exploring historical progress, controversial issues, and prominent opinions in the field. Join us in advancing knowledge and understanding in the realm of diabetes and metabolism.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书